CN110693032A - 一种含有左旋肉碱和雨生红球藻的食品 - Google Patents
一种含有左旋肉碱和雨生红球藻的食品 Download PDFInfo
- Publication number
- CN110693032A CN110693032A CN201910881530.4A CN201910881530A CN110693032A CN 110693032 A CN110693032 A CN 110693032A CN 201910881530 A CN201910881530 A CN 201910881530A CN 110693032 A CN110693032 A CN 110693032A
- Authority
- CN
- China
- Prior art keywords
- carnitine
- sperm
- haematococcus pluvialis
- vitamin
- food containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 title claims abstract description 26
- 241000168517 Haematococcus lacustris Species 0.000 title claims abstract description 24
- 235000013305 food Nutrition 0.000 title claims abstract description 13
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 19
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 16
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 16
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims abstract description 14
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 11
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000011575 calcium Substances 0.000 claims abstract description 11
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 11
- 235000001465 calcium Nutrition 0.000 claims abstract description 11
- 235000011649 selenium Nutrition 0.000 claims abstract description 11
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 11
- 239000011669 selenium Substances 0.000 claims abstract description 11
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 9
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 9
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 9
- 239000011709 vitamin E Substances 0.000 claims abstract description 9
- 229940046009 vitamin E Drugs 0.000 claims abstract description 9
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 8
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 8
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 8
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims abstract description 8
- 235000013734 beta-carotene Nutrition 0.000 claims abstract description 8
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims abstract description 8
- 239000011648 beta-carotene Substances 0.000 claims abstract description 8
- 229960002747 betacarotene Drugs 0.000 claims abstract description 8
- 229960000304 folic acid Drugs 0.000 claims abstract description 8
- 235000019152 folic acid Nutrition 0.000 claims abstract description 8
- 239000011724 folic acid Substances 0.000 claims abstract description 8
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 8
- 239000011718 vitamin C Substances 0.000 claims abstract description 8
- 235000016804 zinc Nutrition 0.000 claims abstract description 8
- 239000011701 zinc Substances 0.000 claims abstract description 8
- 229910052725 zinc Inorganic materials 0.000 claims abstract description 8
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims abstract description 8
- 229940091258 selenium supplement Drugs 0.000 claims abstract description 6
- 229960001518 levocarnitine Drugs 0.000 claims description 5
- 230000021595 spermatogenesis Effects 0.000 abstract description 4
- 230000000694 effects Effects 0.000 description 10
- 230000019100 sperm motility Effects 0.000 description 10
- 210000000582 semen Anatomy 0.000 description 9
- 208000007466 Male Infertility Diseases 0.000 description 7
- 239000003814 drug Substances 0.000 description 7
- 208000000509 infertility Diseases 0.000 description 6
- 230000036512 infertility Effects 0.000 description 6
- 231100000535 infertility Toxicity 0.000 description 6
- 230000003078 antioxidant effect Effects 0.000 description 5
- 230000004899 motility Effects 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 239000003963 antioxidant agent Substances 0.000 description 4
- 235000006708 antioxidants Nutrition 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 230000035558 fertility Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 3
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 3
- 235000013793 astaxanthin Nutrition 0.000 description 3
- 239000001168 astaxanthin Substances 0.000 description 3
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 3
- 229940022405 astaxanthin Drugs 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 150000001746 carotenes Chemical class 0.000 description 3
- 235000005473 carotenes Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 229940068196 placebo Drugs 0.000 description 3
- 239000000902 placebo Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- 241000252229 Carassius auratus Species 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 230000004720 fertilization Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000021267 infertility disease Diseases 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000003859 lipid peroxidation Effects 0.000 description 2
- 230000033001 locomotion Effects 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 210000001550 testis Anatomy 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 206010009260 Cleft lip and palate Diseases 0.000 description 1
- 206010010947 Coordination abnormal Diseases 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 206010048259 Zinc deficiency Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 108091092356 cellular DNA Proteins 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 208000016653 cleft lip/palate Diseases 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000000918 epididymis Anatomy 0.000 description 1
- 201000010063 epididymitis Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000016290 incoordination Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000003228 microsomal effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 201000010193 neural tube defect Diseases 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000036542 oxidative stress Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 230000006825 purine synthesis Effects 0.000 description 1
- 230000006824 pyrimidine synthesis Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 230000008010 sperm capacitation Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 210000004340 zona pellucida Anatomy 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Inorganic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
一种本发明能够增加***发生,一种含有左旋肉碱和雨生红球藻的食品,包括左旋肉碱、雨生红球藻、β‑胡萝卜素、叶酸、锌、硒、维生素C、维生素E和钙,本发明促进***增生和成熟,为***供能,增加***活力,保护***细胞膜的完整性,增加***DNA稳定性,全面提升***品质,故能收到满意效果。
Description
技术领域
本发明涉及保健食品领域,具体涉及一种含有左旋肉碱和雨生红球藻的食品。
背景技术
由于男性因素而导致的***不育症称***,***是一种发病率较高且较难治愈的病症。国内外目前研究资料表明:***不育症在育龄期夫妇中的发病率约为15%-20%,根据世界卫生组织统计:全球大约有600-8000万对夫妇患有不同程度的不育症,其中由男性因素导致的不育约占所有不育夫妇的50%。
中国人口基数大,且相对世界水平发病几率较高,近年来也呈上升趋势。不育症往往造成夫妻感情不和,婚姻家庭破裂,给社会带来不稳定因素。男性不育的病因多种多样,最常见且最直接的外在表现为***品质下降。目前我国医药技术领域在治疗***方面积累了较为丰富的经验,有西医治疗,如采用药物、手术、局部用药等,也有许多有效的中成药,如补肾种子方、补肾生精丸、温肾丸、育精丸等,虽然这些治疗方法在治疗不育症方面各有其优点,但是每种方法都存在一定的局限性。且药物治疗持续时间长,并伴有众多副作用,手术治疗创伤大。且由于中华民族的传统,人们更愿意优先选择食补。因此,提供一种效果显著、无副作用、能改善***质量、加快男性***形成、提高生育能力的组合物及普通食品具有重要的现实意义。
发明内容
本发明针对现有技术的不足,提出一种无副作用,科学有效,能改善***质量,加快男性***形成,提高生育能力含有虾青素和海藻糖的保健食品,具体技术方案如下:
一种含有左旋肉碱和雨生红球藻的食品,包括左旋肉碱和雨生红球藻,其中所述左旋肉碱和雨生红球藻的质量比为(200-3400):(100-1800)。
为更好的实现本发明,进一步为:
还包括β-胡萝卜素、叶酸、锌、硒、维生素C、维生素E或钙中的一种或多种。
以重量计,组分具体为;
本发明有益效果:
左旋肉碱:是维持人体正常生理活动的必需成分。它具有非常重要且多样的作用。左旋肉碱是人体内转运供能物质的重要载体,一方面,附睾与***中含有大量的左旋肉碱,它能将长链脂肪酸转运入***线粒体内进行β氧化,为***运动提供线粒体,另一方面,它还能够将代谢产生的乙酰基、乳酸等废物转运出***,维持***正常功能[9]。此外,该物质还具有较强的还原性,能够降低***内的氧化应激反应水平,保护***的结构[10]。有文献证实,培养基中添加该物质能够增加***的活力、***密度和***DNA的完整性。
雨生红球藻:雨生红球藻的主要含量虾青素是迄今为止人类发现自然界最强的抗氧化剂,其抗氧化活性远远超过现有的抗氧化剂,它能有效清除细胞内的氧自由基,增强细胞再生能力,维持机体平衡和减少衰老细胞的堆积,由内而外保护细胞和DNA健康。虾青素可以改善人类***的活力,增加***穿越透明带的能力,并增加***症患者在一个人工受精周期中的受孕成功率。雨生红球藻可维护***的正常形态和DNA完整性。
β-胡萝卜素:β-胡萝卜素是一种抗氧化剂,能维护微粒体膜完整,细胞微粒体膜完整性能阻止氧自由基产生,可刺激皮肤的新陈代谢,增进血液循环。
叶酸:叶酸是一种水溶性维生素,对蛋白质合成及各种氨基酸的代谢有重要作用,并参与嘌呤和嘧啶合成,在细胞DNA合成中发挥作用。它能够预防胎儿低体重、唇腭裂、心脏缺陷和神经管发育缺陷等畸形。
锌:该物质大量存在于男性睾丸中,参与***的整个生成、成熟和获能的过程。男性一旦缺锌,就会导致***数量减少、活力下降、***液化不良,最终导致男性不育。缺锌还会导致青少年没有***出现、不能正常生殖发育。
硒:该物质是***中过氧化物酶的必需组成成份,***患者***中硒水平普遍偏低,研究发现:***中硒水平越高,***数量越多,活力越强。硒具有强大的抗氧化作用,可清除过剩的自由基,抑制脂质过氧化作用。***患者***硒水平低,自然会削弱机体自身对***中存在的氧自由基的清除和脂质过氧化的抑制,从而导致患者***活力低下,死亡率高,引发不育症。
维生素C:在人体内,维生素C是高效抗氧化剂,许多重要的生物合成过程中也需要维生素C参与作用,维生素C可提高***质量。
维生素E:维生素E能维持生殖功能。维生素E水解能够产生生育酚,使男子***活力和数量增加,提高男性***的质量和活力。
钙:钙是影响***运动能力的重要矿物质,缺乏钙可导致***运动能力的下降。
左旋肉碱以及本发明提供的组合物能够增加***发生,促进***增生和成熟,为***供能,增加***活力,保护***细胞膜的完整性,增加***DNA稳定性,全面提升***品质,故能收到满意效果。
具有以下优点:1、疗效较好,服用后能促进睾丸曲细精管***功能改善、增强性机能、促进***生成、提高***活力,有效提高生育能力;2、适用范围广,适用于各种年龄人群,尤其是对因年龄增大导致生育能力下降有较好疗效,且无明显副作用。
附图说明
图1为本发明中金鱼食用含50、100、150mg胡萝卜素的饮食后,***各项指标的变化;
图2为本发明中在治疗周期内,左旋肉碱和安慰剂处理后***浓度、前向***、直线运动指数等参数的变化表格;
图3为本发明中细胞外钙浓度对***活力的影响示意图。
具体实施方式
下面结合附图对本发明的较佳实施例进行详细阐述,以使本发明的优点和特征能更易于被本领域技术人员理解,从而对本发明的保护范围做出更为清楚明确的界定。
实施例一:
一种含有左旋肉碱和雨生红球藻的食品,包括左旋肉碱、雨生红球藻、β-胡萝卜素、叶酸、锌、硒、维生素C、维生素E和钙。按照重量组分制成粉剂为;
每日1袋,晨起顿服,30天为一疗程,共服用3疗程。
实施例二:
一种含有左旋肉碱和雨生红球藻的食品,包括左旋肉碱、雨生红球藻、β-胡萝卜素、叶酸、锌、硒、维生素C、维生素E和钙中。按照重量组分制成粉剂为;
每日1袋,晨起顿服,30天为一疗程,共服用2疗程。
实施例三:
一种含有左旋肉碱和雨生红球藻的食品,包括左旋肉碱、雨生红球藻、β-胡萝卜素、叶酸、锌、硒、维生素C、维生素E和钙中。按照重量组分制成粉剂为;
每日1袋,晨起顿服,30天为一疗程,共服用4疗程。
实验验证:如图1所示:金鱼食用含50、100、150mg胡萝卜素的饮食后,***各项指标的变化。150毫克/千克胡萝卜素的渗透压,***活力,受精率和***浓度显著高于对照组。
如图2所示:在治疗周期内,左旋肉碱和安慰剂处理后***浓度、前向***、直线运动指数等参数的变化。在左旋肉碱处理后,总***活力、前向***、***浓度和直线运动指数的变化均较安慰剂处理后的变化显著。
如图3所示:细胞外钙浓度对***活力的影响。10μM的细胞外钙离子浓度是获得最佳***活力的最佳浓度。
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910881530.4A CN110693032A (zh) | 2019-09-18 | 2019-09-18 | 一种含有左旋肉碱和雨生红球藻的食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910881530.4A CN110693032A (zh) | 2019-09-18 | 2019-09-18 | 一种含有左旋肉碱和雨生红球藻的食品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110693032A true CN110693032A (zh) | 2020-01-17 |
Family
ID=69194858
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910881530.4A Pending CN110693032A (zh) | 2019-09-18 | 2019-09-18 | 一种含有左旋肉碱和雨生红球藻的食品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110693032A (zh) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106668507A (zh) * | 2016-12-29 | 2017-05-17 | 昭远制药(上海)有限公司 | 一种用于治疗男性***不育的药物及其制备方法 |
CN107157969A (zh) * | 2017-06-15 | 2017-09-15 | 中盐工程技术研究院有限公司 | 一种天然雨生红球藻虾青素软胶囊 |
CN107536055A (zh) * | 2017-10-19 | 2018-01-05 | 杭州鑫伟低碳技术研发有限公司 | 一种辅助治疗***不育的雨生红球藻虾青素产品配方 |
CN107889889A (zh) * | 2017-10-26 | 2018-04-10 | 杭州鑫伟低碳技术研发有限公司 | 一种有助于产妇恢复的雨生红球藻虾青素奶粉的配方 |
CN108041588A (zh) * | 2017-12-08 | 2018-05-18 | 冯纪敏 | 一种含有海藻糖的组合物及其应用 |
-
2019
- 2019-09-18 CN CN201910881530.4A patent/CN110693032A/zh active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106668507A (zh) * | 2016-12-29 | 2017-05-17 | 昭远制药(上海)有限公司 | 一种用于治疗男性***不育的药物及其制备方法 |
CN107157969A (zh) * | 2017-06-15 | 2017-09-15 | 中盐工程技术研究院有限公司 | 一种天然雨生红球藻虾青素软胶囊 |
CN107536055A (zh) * | 2017-10-19 | 2018-01-05 | 杭州鑫伟低碳技术研发有限公司 | 一种辅助治疗***不育的雨生红球藻虾青素产品配方 |
CN107889889A (zh) * | 2017-10-26 | 2018-04-10 | 杭州鑫伟低碳技术研发有限公司 | 一种有助于产妇恢复的雨生红球藻虾青素奶粉的配方 |
CN108041588A (zh) * | 2017-12-08 | 2018-05-18 | 冯纪敏 | 一种含有海藻糖的组合物及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Carroll et al. | Influence of stress and nutrition on cattle immunity | |
Bai et al. | Glutamine improves the growth performance, serum biochemical profile and antioxidant status in broilers under medium-term chronic heat stress | |
CN105768108A (zh) | 一种适用于肿瘤患者服用的特膳食品 | |
EP2481300B1 (en) | Nutritional composition for equine reproductive health | |
Aramli et al. | Effect of dietary antioxidant supplements (selenium forms, alpha-tocopherol, and coenzyme Q10) on growth performance, immunity, and physiological responses in rainbow trout (Oncorhynchus mykiss) using orthogonal array design | |
CN110584116A (zh) | 一种含有雨生红球藻和海藻糖的食品 | |
CN102793184A (zh) | 一种复合抗氧化营养补充剂及其加工方法 | |
RU2018129357A (ru) | Применение имитирующей ограничение питания диеты для повышения эффективности антиэстрогенов при терапии рака | |
US20160367500A1 (en) | Compositions comprising vitamin c, vitamin e, and coenzyme q10 and use thereof for promoting female fertility and reproductive health | |
CN110693032A (zh) | 一种含有左旋肉碱和雨生红球藻的食品 | |
CN104222624A (zh) | 一种奶牛维生素预混料及其制备方法 | |
CN101401649A (zh) | 可增强机体免疫力的组合物 | |
CN108041588A (zh) | 一种含有海藻糖的组合物及其应用 | |
CN110613124A (zh) | 一种含有左旋肉碱和虾青素的保健食品 | |
CA2134707A1 (en) | Methods and compositions for retarding the aging process | |
CN110558563A (zh) | 一种含有板栗多糖和左旋肉碱的保健组合物 | |
CN108371709A (zh) | 黑枸杞肿瘤康复基因酶 | |
CN102613576A (zh) | ***健康美丽营养片 | |
KR102549896B1 (ko) | 피롤로퀴놀린퀴논 또는 그의 염과 분지쇄 아미노산을 포함하는 캡슐 | |
Bendich | Issues in retinoid and carotenoid research | |
Sonawane et al. | A Review Article on ‘Spirulina’ | |
Falahat Naserabad et al. | Effects of selenium nanoparticles on the performance of antioxidant enzymes and ions of rainbow trout eggs (Oncorhynchus mykiss) | |
RU2317073C1 (ru) | Способ профилактики послеродовых заболеваний у коров | |
CN105707890A (zh) | 一种适用于备孕期女性服用的软胶囊 | |
JP6851060B2 (ja) | 造血幹細胞の分化促進剤 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20200117 |